Skip to content

OTR Blank-Check Company to Merge With Comera Life Sciences

  • Massachusetts-based Comera Life develops biologic medicines
  • Combined entity to have initial equity value of $258.4 million

Comera Life Sciences Inc. has agreed to go public through a merger with OTR Acquisition Corp., a blank-check company.

The combined company will have an initial equity value of about $258.4 million, according to a statement seen by Bloomberg. It will provide about $107 million in gross cash proceeds, the companies said.